Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

980 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium.
Kletzel M, Abella EM, Sandler ES, Williams LL, Ogden AK, Pollock BH, Wall DA. Kletzel M, et al. Among authors: wall da. J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):49-54. doi: 10.1097/00043426-199801000-00008. J Pediatr Hematol Oncol. 1998. PMID: 9482413 Clinical Trial.
Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): a phase I study of the Pediatric Blood and Marrow Transplant Consortium.
Sandler ES, Hagg R, Coppes MJ, Mustafa MM, Gamis A, Kamani N, Wall D. Sandler ES, et al. Among authors: wall d. Med Pediatr Oncol. 2000 Oct;35(4):403-9. doi: 10.1002/1096-911x(20001001)35:4<403::aid-mpo2>3.0.co;2-m. Med Pediatr Oncol. 2000. PMID: 11025470 Clinical Trial.
Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children's Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee.
Grupp SA, Frangoul H, Wall D, Pulsipher MA, Levine JE, Schultz KR. Grupp SA, et al. Among authors: wall d. Pediatr Blood Cancer. 2006 Apr;46(4):414-21. doi: 10.1002/pbc.20800. Pediatr Blood Cancer. 2006. PMID: 16463346 Review.
Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.
Gilman AL, Jacobsen C, Bunin N, Levine J, Goldman F, Bendel A, Joyce M, Anderson P, Rozans M, Wall DA, Macdonald TJ, Simon S, Kadota RP. Gilman AL, et al. Pediatr Blood Cancer. 2011 Sep;57(3):506-13. doi: 10.1002/pbc.22899. Epub 2010 Dec 1. Pediatr Blood Cancer. 2011. PMID: 21744474 Free article. Clinical Trial.
Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.
Grupp SA, Dvorak CC, Nieder ML, Levine JE, Wall DA, Langholz B, Pulsipher MA; COG Stem Cell Transplant Scientific Committee. Grupp SA, et al. Pediatr Blood Cancer. 2013 Jun;60(6):1044-7. doi: 10.1002/pbc.24437. Epub 2012 Dec 19. Pediatr Blood Cancer. 2013. PMID: 23255402 Free PMC article. Review.
A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium.
Zorzi AP, Bernstein M, Samson Y, Wall DA, Desai S, Nicksy D, Wainman N, Eisenhauer E, Baruchel S. Zorzi AP, et al. Among authors: wall da. Pediatr Blood Cancer. 2013 Nov;60(11):1868-74. doi: 10.1002/pbc.24694. Epub 2013 Jul 25. Pediatr Blood Cancer. 2013. PMID: 23893953 Clinical Trial.
980 results